Registered outcomes12

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

1 to 12 of 12

List	Outcome	Time frame	Description
Primary	Change in HbA1c	12 weeks	Change in HbA1c from baseline to Week 12 in each genotype group (TT or CC), comparing: TT + Berberine vs. TT + Metformin
Primary	Change in HbA1c from baseline (CC + Berberine vs. CC + Metformin)	12 weeks
Secondary	Fasting Plasma Glucose change (FPG)	12 weeks
Secondary	Postprandial Glucose (PPG) change	12 weeks
Secondary	Serum Insulin Levels	12 weeks
Secondary	HOMA-IR change	12 weeks
Secondary	Body Weight in kg change	12 weeks
Secondary	Total Cholesterol change	12 weeks
Secondary	Triglycerides change	12 weeks
Secondary	LDL-C change	12 weeks
Secondary	HDL-C change	12 weeks
Secondary	Number of any adverce events	12 weeks

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT06911983/registered